2022 BIO International Convention News
Struggle to include women in clinical trials continues despite gainsJune 16, 2022 -- Though female participation in clinical trials has been steadily improving over the years, most of the women enrolled in trials are white and not members of minority groups. ScienceBoard.net spoke with Kathryn Schubert, president and CEO of the Society for Women's Health Research, about inclusivity in clinical trials at the 2022 Biotechnology Innovation Organization International Convention in San Diego.
Patient advocacy organizations look to partner with pharma companiesJune 14, 2022 -- Patient advocacy organizations are looking to partner with pharmaceutical companies, offering resources and expertise to maximize the impact and efficiency of their therapeutic R&D programs. It’s a message that these groups want to drive home to pharma at the 2022 Biotechnology Innovation Organization International Convention in San Diego.
How to develop a sustainable portfolio for cell, gene therapy platformsJune 13, 2022 -- Michael Retterath, a Biotechnology Innovation Organization International Convention 2022 panelist and chief business officer at Spark Therapeutics, spoke to ScienceBoard.net about his company’s transition from a research center to a private, venture-backed startup and a publicly traded company.
Biotech industry execs, not scientists, remain male-dominatedJune 13, 2022 -- A panel at the 2022 Biotechnology Innovation Organization International Convention will explore how to close the gender gap in the biotech industry and how it can become more inclusive. ScienceBoard.net spoke with Nasha Fitter, co-founder and CEO of the FOXG1 Research Foundation, who will participate in the June 14 panel at the convention.
The ‘voice of the patient’ needs to be heard in clinical trials: studyJune 10, 2022 -- Patient recruitment and retention are among the biggest challenges facing clinical research, particularly in studies targeting rare diseases that have a limited pool of patients, contends Clincierge CEO Scott Gray. He spoke with ScienceBoard.net about Clincierge's study examining the patient experience in clinical trials of rare diseases.
Biotech innovator recounts decades-long journey to create drug discovery technologyJune 8, 2022 -- Dr. Stan Crooke, PhD, founder, chairman, and chief executive officer of RNA therapy company Ionis Pharmaceuticals, pioneered development of the antisense technology platform and created one of the largest, most advanced pipelines in the biotech industry. Crooke shared his story in an interview with ScienceBoard.net.